Wu, S <br/><br/>
All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1.  [electronic resource] 

 -  Experimental cell research  May 1997 
 - 277-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0014-4827 
<br/><br/><label>Standard No.: </label>10.1006/excr.1997.3495  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cattle<br/>Cell Division--drug effects<br/>DNA Replication--drug effects<br/>DNA, Neoplasm--biosynthesis<br/>Estradiol--pharmacology<br/>Female<br/>Fetal Blood--physiology<br/>G1 Phase--drug effects<br/>Growth Inhibitors--pharmacology<br/>Humans<br/>Insulin--pharmacology<br/>Insulin-Like Growth Factor I--pharmacology<br/>Neoplasm Proteins--biosynthesis<br/>Ovarian Neoplasms--pathology<br/>RNA, Messenger--biosynthesis<br/>RNA, Neoplasm--biosynthesis<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta--biosynthesis<br/>Tretinoin--pharmacology<br/>Tumor Cells, Cultured--drug effects